Imaging of Colorectal Liver Metastasis

Azarakhsh Baghdadi, Sahar Mirpour, Maryam Ghadimi, Mina Motaghi, Bita Hazhirkarzar, Timothy M. Pawlik, Ihab R. Kamel

Research output: Contribution to journalReview articlepeer-review


Colorectal cancer (CRC) is one of the most common cancers in the world. The most important determinant of survival and prognosis is the stage and presence of metastasis. The liver is the most common location for CRC metastasis. The only curative treatment for CRC liver metastasis (CRLM) is resection; however, many patients are ineligible for surgical resection of CRLM. Locoregional treatments such as ablation and intra-arterial therapy are also available for patients with CRLM. Assessment of response after chemotherapy is challenging due to anatomical and functional changes. Antiangiogenic agents such as bevacizumab that are used in the treatment of CRLM may show atypical patterns of response on imaging. It is vital to distinguish patterns of response in addition to toxicities to various treatments. Imaging plays a critical role in evaluating the characteristics of CRLM and the approach to treatment. CT is the modality of choice in the diagnosis and management of CRLM. MRI is best used for indeterminate lesions and to assess response to intra-arterial therapy. PET-CT is often utilized to detect extrahepatic metastasis. State-of-the-art imaging is critical to characterize patterns of response to various treatments. We herein review the imaging characteristics of CRLM with an emphasis on imaging changes following the most common CRLM treatments.

Original languageEnglish (US)
Pages (from-to)245-257
Number of pages13
JournalJournal of Gastrointestinal Surgery
Issue number1
StatePublished - Jan 2022


  • CT
  • Colorectal cancer
  • Imaging
  • Liver metastasis
  • MRI

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology


Dive into the research topics of 'Imaging of Colorectal Liver Metastasis'. Together they form a unique fingerprint.

Cite this